Abstract
The use of nanoemulsions as a carrier system for skin targeting has attracted increased attention over recent years. Nanoemulsions can be intended for both topical and systemic delivery of the biologically active agents for controlled and targeted delivery. Nanoemulsion droplets fall within the size range of 20-200nm, typically below 100nm. Nanoemulsions have high surface area and ability to solubilize poorly soluble drugs. They are reported to have higher skin permeation and retention potential than other novel drug delivery systems like nanoparticles, liposomes, microemulsions etc. Use of nanoemulsions for skin targeting of drug is a current research scenario in the field of Pharmaceutics. This research area has generated immense interest from the Pharmaceutical industry and a number of nanoemulsion based cosmetics formulations like anti-aging creams, skin cleansing lotions etc. are available in the market. Recently, Zydus Cadilla launched the Oxalgin NanoGel™ diclofenac sodium nanoemulsion gel showing the importance of nanoemulsion as carrier system for skin targeting of drugs. This review embodies an in-depth discussion on composition, application, its mechanism of skin permeation and commercial aspects of nanoemulsions for skin targeting.
Keywords: Anti-acne, skin targeting, nanoemulsion, NSAIDs, commercial products, anti-fungal, anti-cancer, TOPICAL DELIVERY, Anti-Cancer Drugs
Drug Delivery Letters
Title: Nanoemulsions for Skin Targeting: Present Status and Future Prospects
Volume: 1 Issue: 2
Author(s): Mukta Singh and Subheet Jain
Affiliation:
Keywords: Anti-acne, skin targeting, nanoemulsion, NSAIDs, commercial products, anti-fungal, anti-cancer, TOPICAL DELIVERY, Anti-Cancer Drugs
Abstract: The use of nanoemulsions as a carrier system for skin targeting has attracted increased attention over recent years. Nanoemulsions can be intended for both topical and systemic delivery of the biologically active agents for controlled and targeted delivery. Nanoemulsion droplets fall within the size range of 20-200nm, typically below 100nm. Nanoemulsions have high surface area and ability to solubilize poorly soluble drugs. They are reported to have higher skin permeation and retention potential than other novel drug delivery systems like nanoparticles, liposomes, microemulsions etc. Use of nanoemulsions for skin targeting of drug is a current research scenario in the field of Pharmaceutics. This research area has generated immense interest from the Pharmaceutical industry and a number of nanoemulsion based cosmetics formulations like anti-aging creams, skin cleansing lotions etc. are available in the market. Recently, Zydus Cadilla launched the Oxalgin NanoGel™ diclofenac sodium nanoemulsion gel showing the importance of nanoemulsion as carrier system for skin targeting of drugs. This review embodies an in-depth discussion on composition, application, its mechanism of skin permeation and commercial aspects of nanoemulsions for skin targeting.
Export Options
About this article
Cite this article as:
Singh Mukta and Jain Subheet, Nanoemulsions for Skin Targeting: Present Status and Future Prospects, Drug Delivery Letters 2011; 1(2) . https://dx.doi.org/10.2174/2210304x11101020159
DOI https://dx.doi.org/10.2174/2210304x11101020159 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
IT-143, A Polymer Micelle Nanoparticle, Widens Therapeutic Window of Daunorubicin
Pharmaceutical Nanotechnology Outcome-Dependent Global Similarity Analysis of Imbalanced Core Signaling Pathways in Ischemic Mouse Hippocampus
CNS & Neurological Disorders - Drug Targets An Overview of the α4β1 Integrin and the Potential Therapeutic Role of its Antagonists
Current Medicinal Chemistry Functional PLGA NPs for Oral Drug Delivery: Recent Strategies and Developments
Mini-Reviews in Medicinal Chemistry Daclizumab: A Potential Asthma Therapy?
Recent Patents on Inflammation & Allergy Drug Discovery Gonadotropin-Releasing Hormone (GnRH) Receptors in Tumors: a New Rationale for the Therapeutical Application of GnRH Analogs in Cancer Patients?
Current Cancer Drug Targets A New Synthetic Spiroketal: Studies on Antitumor Activity on Murine Melanoma Model In Vivo and Mechanism of Action In Vitro
Anti-Cancer Agents in Medicinal Chemistry Patent Selections
Recent Patents on Inflammation & Allergy Drug Discovery Nano Drug Delivery in Treatment of Oral Cancer, A Review of the Literature
Current Drug Targets Antibodies for Therapeutic Uses and the Evolution of Biotechniques
Current Medicinal Chemistry Monitoring Molecular, Functional and Morphologic Aspects of Bone Metastases Using Non-Invasive Imaging
Current Pharmaceutical Biotechnology Discovery of Small Molecule c-Met Inhibitors: Evolution and Profiles of Clinical Candidates
Anti-Cancer Agents in Medicinal Chemistry Fragment-Based Drug Discovery and Molecular Docking in Drug Design
Current Pharmaceutical Biotechnology Involvement of the Toxic AGEs (TAGE)-RAGE System in the Pathogenesis of Diabetic Vascular Complications: A Novel Therapeutic Strategy
Current Drug Targets Roles of Fluorine in Drug Design and Drug Action
Letters in Drug Design & Discovery Liposome-Encapsulated Photosensitizers Against Bacteria
Recent Patents on Anti-Infective Drug Discovery Estrone (E1) Based Esters as Potential Inhibitors of Type 3 17β- hydroxysteroid Dehydrogenase (17β-HSD3) in the Treatment of Hormone-Dependent Prostate Cancer
Letters in Drug Design & Discovery From Pituitary Adenoma to Pituitary Neuroendocrine Tumors: How Molecular Pathways may Impact the Therapeutic Management?
Endocrine, Metabolic & Immune Disorders - Drug Targets Thapsigargin, Origin, Chemistry, Structure-Activity Relationships and Prodrug Development
Current Pharmaceutical Design Perspectives of Benzimidazole Derivatives as Anticancer Agents in the New Era
Anti-Cancer Agents in Medicinal Chemistry